entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
101928079,SLC44A3-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,24.1970450567373,-0.0697433849268895,0.413280826406771,-0.168755433280722,0.865989014545275,0.977464818051979,NA
101928079,SLC44A3-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,5.57948483626276,2.01371818271208,0.870582222322289,2.31307064522919,0.0207187553455313,0.133256305821545,patient-derived GBM cell lines (PDGCLs)
101928079,SLC44A3-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,34.0491782875795,0.976248788816627,0.374096389820262,2.60961831063292,0.00906432962593784,0.048013438439384,A549
101928079,SLC44A3-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,11.6760936740526,0.961736851132075,0.587231725750091,1.63774675134184,0.101474533646289,0.7668240801226,A549
101928079,SLC44A3-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,8.32198886072676,-6.32174174681234,1.75291286812691,-3.60642098176135,0.000310449336541355,0.00131563509866125,A549
101928079,SLC44A3-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,219.810684379991,0.190811306118989,0.19899744019668,0.958863118693383,0.337627706658645,1,sigmoid colon organoid
101928079,SLC44A3-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,219.810684379991,0.148183563508599,0.198983825512177,0.744701551129498,0.456452161259712,1,sigmoid colon organoid
